Hiroshi Maeda
Impact in
- Biomaterials top 0.01%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.02%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Biomaterials 57
- Nanoparticle-Based Drug Delivery 52
- Biophysics 19
- Electron Spin Resonance Studies 19
- Co-authors
- Yasuhiro MatsumuraJun FangHideaki NakamuraTomohiro SawaJun WuK. HoriKhaled GreishArun K. Iyer
- Journals
- Journal of Controlled Release (14 papers)Advanced Drug Delivery Reviews (9 papers)The Journal of Biochemistry (7 papers)Cancer Science (6 papers)Bioconjugate Chemistry (6 papers)
- Partner nations
- JapanUnited StatesCzechia
In The Last Decade
Hiroshi Maeda
243 papers receiving 36.6k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Biomaterials 18.9k
- Biomedical Engineering 15.8k
- Pharmaceutical Science 1.5k
- Molecular Biology 14.4k
- Molecular Medicine 970
Countries citing papers authored by Hiroshi Maeda
This map shows the geographic impact of Hiroshi Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Maeda more than expected).
Fields of papers citing papers by Hiroshi Maeda
This network shows the impact of papers produced by Hiroshi Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Maeda. The network helps show where Hiroshi Maeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 77 | |
| 2 | 2015 | 40 | |
| 3 | 2015 | 25 | |
| 4 | Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity Hit paper breakdown → | 2015 | 954 |
| 5 | 2014 | 43 | |
| 6 | 2009 | 149 | |
| 7 | 2008 | 1 | |
| 8 | 2008 | 39 | |
| 9 | 2007 | 14 | |
| 10 | 2003 | 3 | |
| 11 | 2001 | 455 | |
| 12 | Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review Hit paper breakdown → | 2000 | 5269 |
| 13 | 1998 | 370 | |
| 14 | 1994 | 13 | |
| 15 | 1994 | 177 | |
| 16 | 1991 | 19 | |
| 17 | 1991 | 5 | |
| 18 | 1987 | 12 | |
| 19 | 1985 | 1 | |
| 20 | Degradation of neocarzinostatin by blood sera in vitro and its inhibition by diisopropyl fluorophosphate and n-ethylmaleimide. | 1975 | 8 |
About Hiroshi Maeda
Hiroshi Maeda is a scholar working on Biomaterials, Biophysics, Cancer Research, Biotechnology and Molecular Biology, having authored 244 papers that have together received 37.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (52 papers), Nanoplatforms for cancer theranostics (35 papers), Cancer, Hypoxia, and Metabolism (29 papers), Lanthanide and Transition Metal Complexes (26 papers), Electron Spin Resonance Studies (19 papers), Cancer therapeutics and mechanisms (18 papers), Heme Oxygenase-1 and Carbon Monoxide (18 papers) and Chemical Synthesis and Analysis (15 papers). The work is most often cited by research in Biomaterials (18.9k citations), Biomedical Engineering (15.8k citations), Pharmaceutical Science (1.5k citations), Molecular Biology (14.4k citations) and Molecular Medicine (970 citations). Hiroshi Maeda has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Yasuhiro Matsumura, Jun Fang, Hideaki Nakamura, Tomohiro Sawa, Jun Wu, K. Hori, Khaled Greish, Arun K. Iyer, Jurstine Daruwalla and Toshimitsu Konno. Their work appears in journals such as Journal of Controlled Release, Advanced Drug Delivery Reviews, The Journal of Biochemistry, Cancer Science and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.